Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Surge to Save Newborns Act
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Right Drug Dose Now Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNIVERSITY OF SOUTHERN CALIFORNIA via KING & SPALDING LLP
2026 · third_quarter · Q3
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Source: Senate LDA
| ADVENTIST HEALTHCARE |
| 34 |
| 2018–2026 |
| SENIOR CARE PHARMACY COALITION | 33 | 2019–2026 |
| BACARDI U S A INC | 32 | 2005–2014 |
| COMCAST CORPORATION | 26 | 2019–2026 |
| GENENTECH INC | 23 | 2021–2026 |
| KANEKA PHARMA AMERICA, LLC | 21 | 2018–2022 |
| PADRON CIGARS | 21 | 2021–2025 |
| COOPER INDUSTRIES LTD | 20 | 2007–2012 |
| SEABOARD CORPORATION | 20 | 2002–2026 |
| TULSA HOSPITAL COALITION (AD HOC COALITION) | 20 | 2015–2020 |
| BECTON, DICKINSON AND COMPANY | 19 | 2021–2025 |
| Amarin Pharma, Inc. | 18 | 2018–2022 |
| RAC COALITION (INFORMAL COALITION) | 15 | 2013–2016 |
| THE COALITION TO ADVANCE RENEWABLE ENERGY THROUGH BULK STORAGE ("CAREBS") | 14 | 2009–2012 |
| TRANSMEDICS, INC. | 13 | 2021–2024 |
| FLAGLER HEALTH + | 12 | 2021–2023 |
| PRELUDEDX | 12 | 2023–2025 |
| AUDENTES THERAPEUTICS | 11 | 2018–2021 |
| GLOBAL BLOOD THERAPEUTICS | 11 | 2019–2021 |
| MEDICINES COMPANY | 11 | 2006–2009 |
| THE CITY OF MIAMI, FLORIDA | 11 | 2021–2023 |
| BAUSCH HEALTH COMPANIES INC F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL INC | 10 | 2018–2020 |
| BECKER & POLIAKOFF P.A., ON BEHALF OF THE CITY OF MIAMI | 10 | 2023–2025 |
| CHILDREN'S HEALTHCARE OF ATLANTA INC | 10 | 1999–2008 |
| COMMUNITY HEALTH SYSTEMS | 10 | 2020–2023 |
| QUEST DIAGNOSTICS | 9 | 2021–2023 |
| ST. PETERSBURG COLLEGE FOUNDATION, INC. | 9 | 2024–2025 |
| DAVITA INC. | 8 | 2007–2009 |
| SEDGWICK, INC. | 8 | 2014–2018 |
| AMERICAN REGENT, INC. | 7 | 2020–2021 |
| COVANTA ENERGY CORPORATION | 7 | 2008–2009 |
| LIFEGIFT | 7 | 2025–2026 |
| MR JULIAN H ROBERTSON | 7 | 2007–2008 |
| NATIONAL LEAGUE OF CITIES | 7 | 2021–2022 |
| RAGAN & MASSEY, LLC. | 7 | 2024–2026 |
| SPRINT NEXTEL CORPORATION | 7 | 2006–2008 |
| ALBANY MEDICAL CENTER | 6 | 2011–2012 |
| FLAGLER COLLEGE | 6 | 2024–2025 |
| KIDNEY TRANSPLANT COLLABORATIVE | 6 | 2023–2024 |
| MICROSOFT CORPORATION | 6 | 2021–2022 |
| WEG ELECTRIC CORPORATION | 6 | 2025–2026 |
| AFLAC INCORPORATED | 5 | 2025–2026 |
| COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION | 5 | 2021–2022 |
| FIVE STAR HOLDING LLC | 5 | 2026 |
| GOOGLE INC. | 5 | 2008–2009 |
| HONDURAS PROSPERA INC. | 5 | 2023–2024 |
| QUALITY DIALYSIS CENTER LAS TUNAS LLC | 5 | 2024–2025 |
| STARK REFORM COALITION (INFORMAL COALITION) | 5 | 2016 |
| SWARTHMORE COLLEGE | 5 | 2025–2026 |
| UCB PHARMA INC | 5 | 2004–2007 |
| US ONCOLOGY | 5 | 2007–2009 |
| CGI FEDERAL | 4 | 2025–2026 |
| JA WORLDWIDE | 4 | 2006–2007 |
| MYTOMORROWS | 4 | 2017 |
| PIEDMONT HEALTHCARE INC. | 4 | 2016 |
| STOP THE WAIT COALITION | 4 | 2021 |
| ALBANY AREA CHAMBER OF COMMERCE | 3 | 2004–2005 |
| BETHUNE-COOKMAN UNIVERSITY | 3 | 2025–2026 |
| BONE GROWTH STIMULATOR COALITION (INFORMAL COALITION) | 3 | 2011 |
| BRIDGESTONE-FIRESTONE | 3 | 2000–2001 |
| COALITION TO IMPROVE HEALTHCARE STAFFING | 3 | 2008 |
| ID BIOMEDICAL CORP | 3 | 2004–2005 |
| MINNESOTA MINING & MANUFACTURING CO (3M) | 3 | 1999–2001 |
| MOLECULIGHT CORPORATION | 3 | 2026 |
| TROVER SOLUTIONS | 3 | 1999–2002 |
| UNITED CDPAP, INC. | 3 | 2024–2025 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | 3 | 2026 |
| ACADIA HEALTHCARE | 2 | 2026 |
| ALTAVIAN, INC. | 2 | 2019 |
| ALUMINUM EXTRUSIONS FAIR TRADE COMMITTEE | 2 | 2011 |
| AMERICAN ASSOCIATION OF INTERNATIONAL HEALTHCARE RECRUITMENT | 2 | 2009 |
| ANIKA THERAPEUTICS, INC. | 2 | 2016 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 2 | 2000–2002 |
| CALIFORNIA STEEL INDUSTRIES | 2 | 2001–2002 |
| CHEVRON USA INC | 2 | 2003 |
| DR. SANJAY BHARTI | 2 | 2017 |
| EAST ALABAMA MEDICAL CENTER | 2 | 2019 |
| ERINMEDIA LLC | 2 | 2005 |
| GEORGIA AMATEUR ATHLETICS FOUNDATION | 2 | 1999 |
| JEFFERSON-PILOT CORP | 2 | 1999 |
| QUIDEL CORP | 2 | 2005 |
| REGAL WARE INC | 2 | 2004 |
| SALT LAKE ORGANIZING COMMITTEE FOR THE OLYMPIC WINTER GAMES OF 2002 | 2 | 2000–2001 |
| SAVANT HWP, INC. | 2 | 2013 |
| THE BRINK'S COMPANY | 2 | 2017 |
| TRAVELERS COMPANIES INC | 2 | 2007 |
| BOEING COMPANY | 1 | 2008 |
| COLLEGE LOAN CORPORATION | 1 | 2006 |
| DETROIT MEDICAL CENTER | 1 | 2008 |
| DUFERCO FARRELL CORPORATION | 1 | 2002 |
| EGG FACTORY LLC | 1 | 2000 |
| GENERAL MOTORS | 1 | 2007 |
| IEM INTERNATIONAL, INC. | 1 | 2026 |
| INTERNET SECURITY SYSTEMS, INC. | 1 | 2001 |
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Right Drug Dose Now Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
Right Drug Dose Now Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Medical Foods and Formulas Access Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
No Surrogacy for Sex Offenders Act
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
No Surrogacy for Sex Offenders Act
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
No Surrogacy for Sex Offenders Act
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Genomic Answers for Children’s Health Act of 2026
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Genomic Answers for Children’s Health Act of 2026
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
Genomic Answers for Children’s Health Act of 2026
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Medical Foods and Formulas Access Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, as well as H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025, as well as H.R. 6208, Access to Genetic Counselor Services Act, and J/R/5684/S3304, Medical Foods and Formulas Access Act.
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026
Client: RAGAN & MASSEY, LLC. · Firm: KING & SPALDING LLP
FY2025 Interior, Environment, and Related Agencies Appropriations Bills (H.R. 4754/S. S 2431) related to uniformity of pesticide labeling.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
No Surrogacy for Sex Offenders Act
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025, as well as H.R. 6208, Access to Genetic Counselor Services Act, and J/R/5684/S3304, Medical Foods and Formulas Access Act.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2026
Client: RAGAN & MASSEY, LLC. · Firm: KING & SPALDING LLP
FY2025 Interior, Environment, and Related Agencies Appropriations Bills (H.R. 4754/S. S 2431) related to uniformity of pesticide labeling.
Medical Foods and Formulas Access Act of 2025
Client: AMERICAN COLLEGE OF MEDICAL GENETICS · Firm: KING & SPALDING LLP
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025, as well as H.R. 6208, Access to Genetic Counselor Services Act, and J/R/5684/S3304, Medical Foods and Formulas Access Act.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Ensuring Kids Have Access to Medically Necessary Dental Care Act
Client: PADRON CIGARS · Firm: KING & SPALDING LLP
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Ensuring Kids Have Access to Medically Necessary Dental Care Act
Client: PADRON CIGARS · Firm: KING & SPALDING LLP
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Ensuring Kids Have Access to Medically Necessary Dental Care Act
Client: PADRON CIGARS · Firm: KING & SPALDING LLP
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Ensuring Kids Have Access to Medically Necessary Dental Care Act
Client: PADRON CIGARS · Firm: KING & SPALDING LLP
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
FDA Regulation of hand-crafted cigars; S. 448; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021.
Organ Donation Clarification Act of 2021
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 3569, Organ Donation Clarification Act of 2021.
H.R. 4859, Patient Accessibility and Access To Community Healthcare (PAATCH) Act
H.R. 4859, Patient Accessibility and Access To Community Healthcare (PAATCH) Act
H.R. 4859, Patient Accessibility and Access To Community Healthcare (PAATCH) Act
H.R. 4859, Patient Accessibility and Access To Community Healthcare (PAATCH) Act
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Advocacy for Medicare Secondary Payer issues; RAMP Act, H.R. 8063 (117th).
Saving Access to Laboratory Services Act
Client: QUEST DIAGNOSTICS · Firm: KING & SPALDING LLP
Issues related to clinical laboratory testing, including H.R. 8188 / S. 4449 - Saving Access to Laboratory Sciences Act.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation (pending number assignment).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation (pending number assignment).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues.
Advocacy related to transportation issues; S.3580, Ocean Shipping Reform Act of 2022 / H.R.4996, Ocean Shipping Reform Act of 2021.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Filing targets: Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), State, Dept of (DOS), White House Office
GENENTECH, INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy Related to Population Health and Access to Healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
COMCAST CORPORATION via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to Broadband Access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IEM INTERNATIONAL INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate on behalf of client regarding manufacturing.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to IEEPA and Section 301 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SWARTHMORE COLLEGE via KING & SPALDING LLP
2026 · third_quarter · Q3
Issues affecting higher education.
SEABOARD CORPORATION via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to Agricultural Industry.
Advocacy related to 301 investigation on shipping fees.
Filing targets: Federal Maritime Commission
AFLAC INCORPORATED via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to fixed indemnity plans and taxation of benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEGIFT via KING & SPALDING LLP
2026 · third_quarter · Q3
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; FY2027 Labor-HHS-Education Appropriations, and H.R. 10571, the Surge to Save Newborns Act.
Filing targets: HOUSE OF REPRESENTATIVES
FIVE STAR HOLDING LLC via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy regarding Tarriffs
Advocacy regarding Manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · third_quarter · Q3
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · third_quarter · Q3
Lobbying on Medicare coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BETHUNE-COOKMAN UNIVERSITY via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocating for the growth and advancement of the university.
Filing targets: HOUSE OF REPRESENTATIVES
COMCAST CORPORATION via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to Broadband Access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy Related to Population Health and Access to Healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to IEEPA and Section 301 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
LIFEGIFT via KING & SPALDING LLP
2026 · second_quarter · Q2
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy on health care issues relating to genetics and genetic testing, including H.R. 4709, the Newborn Screening Saves Lives Reauthorization Act; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 7118, Genomic Answers for Childrens Health Act; H.R. 2471, Right Dose Right Now Act; and FY2027 Labor-HHS-Education Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF SOUTHERN CALIFORNIA via KING & SPALDING LLP
2026 · second_quarter · Q2
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · second_quarter · Q2
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · second_quarter · Q2
Lobbying on Medicare coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SEABOARD CORPORATION via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to 301 investigation on shipping fees.
Advocacy related to Agricultural Industry.
Filing targets: Federal Maritime Commission
AFLAC INCORPORATED via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to fixed indemnity plans and taxation of benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWARTHMORE COLLEGE via KING & SPALDING LLP
2026 · second_quarter · Q2
Issues affecting higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIVE STAR HOLDING LLC via KING & SPALDING LLP
2026 · second_quarter · 2A
Advocacy regarding Tarriffs
Advocacy regarding Manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
RAGAN & MASSEY, LLC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Tariffs and Regulatory Approvals.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
FIVE STAR HOLDING LLC via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy regarding Tarriffs
Advocacy regarding Manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
CGI FEDERAL via KING & SPALDING LLP
2026 · second_quarter · 2T
Federal IT Systems and Services; Federal Acquisition.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES
BETHUNE-COOKMAN UNIVERSITY via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocating for the growth and advancement of the university.
Filing targets: HOUSE OF REPRESENTATIVES
LIFEGIFT via KING & SPALDING LLP
2026 · first_quarter · Q1
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIVE STAR HOLDING LLC via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy regarding Manufacturing
Advocacy regarding Tarriffs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
GENENTECH, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy Related to Population Health and Access to Healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
COMCAST CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to Broadband Access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAGAN & MASSEY, LLC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Tariffs and Regulatory Approvals.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA)
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to IEEPA and Section 301 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy on health care issues relating to genetics and genetic testing, including H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025; H.R. 6208, Access to Genetic Counselor Services Act; H.R. 5684/S 3304, Medical Foods and Formulas Access Act; H.R. 7118, Genomic Answers for Childrens Health Act; and H.R. 2471, Right Dose Right Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CGI FEDERAL via KING & SPALDING LLP
2026 · first_quarter · Q1
Federal IT Systems and Services; Federal Acquisition.
Filing targets: HOUSE OF REPRESENTATIVES
SWARTHMORE COLLEGE via KING & SPALDING LLP
2026 · first_quarter · Q1
Issues affecting higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEABOARD CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to Agricultural Industry.
Advocacy related to 301 investigation on shipping fees.
Filing targets: Federal Maritime Commission
AFLAC INCORPORATED via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to fixed indemnity plans and taxation of benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF SOUTHERN CALIFORNIA via KING & SPALDING LLP
2026 · second_quarter · RR
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
Higher education policy; student aid and workforce development; science, health, economic, and technology policies; public private partnerships; national security and defense research.
FIVE STAR HOLDING LLC via KING & SPALDING LLP
2026 · first_quarter · RR
Advocacy regarding Import Tariffs and U.S. Manufacturing
Advocacy regarding Import Tariffs and U.S. Manufacturing
SWARTHMORE COLLEGE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Issues affecting higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. PETERSBURG COLLEGE FOUNDATION, INC. via KING & SPALDING LLP
2025 · fourth_quarter · 4T
Higher Education and Workforce Development Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEABOARD CORPORATION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to Agricultural Industry.
Advocacy related to 301 investigation on shipping fees.
Filing targets: Federal Maritime Commission
PADRON CIGARS via KING & SPALDING LLP
2025 · fourth_quarter · 4T
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFLAC INCORPORATED via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to fixed indemnity plans and taxation of benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to IEEPA and Section 301 investigations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
LIFEGIFT via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025, as well as H.R. 6208, Access to Genetic Counselor Services Act, and J/R/5684/S3304, Medical Foods and Formulas Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAGAN & MASSEY, LLC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Tariffs on herbicide products.
CGI FEDERAL via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Federal IT Systems and Services; Federal Acquisition.
Filing targets: HOUSE OF REPRESENTATIVES
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BETHUNE-COOKMAN UNIVERSITY via KING & SPALDING LLP
2025 · fourth_quarter · RA
Higher Education and Appropriations.
CGI FEDERAL via KING & SPALDING LLP
2025 · fourth_quarter · RR
Federal IT Systems and Services; Federal Acquisition.
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to IEEPA and Section 301 investigations.
Filing targets: SENATE
WEG ELECTRIC CORPORATION via KING & SPALDING LLP
2025 · third_quarter · RR
Advocacy related to IEEPA and Section 301 Investigations.
SWARTHMORE COLLEGE via KING & SPALDING LLP
2025 · fourth_quarter · RR
Issues affecting higher education.
GENENTECH, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to access to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
COMCAST CORPORATION via KING & SPALDING LLP
2025 · third_quarter · Q3
Broadband access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BECKER & POLIAKOFF P.A., ON BEHALF OF THE CITY OF MIAMI via KING & SPALDING LLP
2025 · third_quarter · Q3
Federal Funding Opportunities for Municipalities.
Filing targets: HOUSE OF REPRESENTATIVES
RAGAN & MASSEY, LLC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Tariffs on herbicide products.
FY2025 Interior, Environment, and Related Agencies Appropriations Bills (H.R. 4754/S. S 2431) related to uniformity of pesticide labeling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFEGIFT via KING & SPALDING LLP
2025 · third_quarter · Q3
Organ donation and Transplantation issues, including H.R. 4470, Removing Burdens From Organ Donation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy on health care issues relating to genetics and genetic testing, including funding and authorization for the Newborn Screening program, as well as H.R.4709, the Newborn Screening Saves Lives Reauthorization Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFLAC INCORPORATED via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to fixed indemnity plans and taxation of benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. PETERSBURG COLLEGE FOUNDATION, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Higher Education and Workforce Development Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SEABOARD CORPORATION via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to Agricultural Industry.
Advocacy related to 301 investigation on shipping fees.
Filing targets: Federal Maritime Commission
PADRON CIGARS via KING & SPALDING LLP
2025 · third_quarter · Q3
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ST. PETERSBURG COLLEGE FOUNDATION, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Higher Education and Workforce Development Issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SEABOARD CORPORATION via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy related to Agricultural Industry.
Advocacy related to 301 investigation on shipping fees.
Filing targets: Federal Maritime Commission
PRELUDEDX via KING & SPALDING LLP
2025 · second_quarter · Q2
Coverage of breast cancer risk assessment test.
Filing targets: HOUSE OF REPRESENTATIVES
PADRON CIGARS via KING & SPALDING LLP
2025 · second_quarter · Q2
FDA Regulation of hand-crafted cigars; Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2021 ( S. 448).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
LIFEGIFT via KING & SPALDING LLP
2025 · second_quarter · Q2
Organ donation and Transplantation issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy related to access to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
BECTON, DICKINSON AND COMPANY via KING & SPALDING LLP
2025 · second_quarter · 2T
Issues affecting manufacturer and direct supplier of medical products and diagnostics, including access, reimbursement, and supply chain considerations.
Filing targets: HOUSE OF REPRESENTATIVES
COMCAST CORPORATION via KING & SPALDING LLP
2025 · second_quarter · Q2
Broadband access.
Filing targets: HOUSE OF REPRESENTATIVES
BECKER & POLIAKOFF P.A., ON BEHALF OF THE CITY OF MIAMI via KING & SPALDING LLP
2025 · second_quarter · Q2
Federal Funding Opportunities for Municipalities and FY 2026 Community Funding.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN COLLEGE OF MEDICAL GENETICS via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy on health care issues relating to genetics and genetic testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Commerce, Dept of (DOC), Education, Dept of, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), State, Dept of (DOS), White House Office